Roche's Webcast Replay on data presented at AAN 2019

Roche has hosted a live audio webcast and conference call on Monday, 13 May 2019.

Agenda:

  • Welcome
    Karl Mahler, Head of Investor Relations
  • Overview of Roche key data at AAN covering new analysis from Ocrevus, satralizumab SakuraSky phase III data, risdiplam one year part I FIREFISH and SUNFISH data and dose selection data for the phase III study in Huntington's Disease
    Paulo Fontoura, Global Head Neuroscience and Rare Diseases Clinical Development
  • Roche Neuroscience and Rare Disease franchise update
    Karsten Jung, Therapeutic Area Head Neuroscience and Rare Diseases
  • Q&A

Please register to access the webcast

* Mandatory

 

The registration form for the webcast is not available.

 

Please come back 30 minutes before the webcast start date and fill in the registration form.